Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer

Anti-Cancer Drugs

Volumn 13, Issue 8, 2002, Pages 833-838

  Oettle, H ^a   Arnold, D ^a   Kern, M ^a   Hoepffner, N ^a   Settmacher, U ^a   Neuhaus, P ^a   Riess, H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

5 Fluorouracil; Adenocarcinoma; Cisplatin; Esophageal cancer; Gemcitabine; Squamous cell carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS CANCER; FEMALE; HUMAN; LEUKOPENIA; MALE; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEOXYCYTIDINE; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED;

EID: 0036747927     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200209000-00008     Document Type: Article

References (22)

1. Devesa S, Blott WJ, Fraumeni JF. Changing patterns in incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
2. Coia LR, Engstrom PF, Paul AR, et al. Long-term results of infusional 5 FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991; 20: 29-36.
3. Roth JA, Putnam JB. Surgery of cancer of the esophagus. Semin Oncol 1994; 21: 453-61.
4. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
5. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000; 18: 868-76.
6. Ilson DH, Saltz L, Enzinger P, et al. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 1999; 17: 3270-5.
7. Enzinger PC, Ilson DH, Kelsen DP. Chemotherapy in esophageal cancer. Semin Oncol 1999; 5(suppl 15): 12-20.
8. Ilson D, Kelsen D. Systemic therapy in esophageal cancer. In: Aisner J, et al., eds. Comprehensive textbook of thoracic oncology. Baltimore, MD: Williams & Wilkins 1996: 630-49.
9. Ilson DH, Ajani J, Bhalla K, et al. Phase II trial of paclitaxel, fluorouracil and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998; 16: 1826-34.
10. Lokich JJ, Sonneborn H, Anderson NR, et al. Combined paclitaxel, cisplatin and etoposide for patients with previously untreated esophageal and gastresophageal carcinomas. Cancer 1999; 85: 2347-51.
11. Ilson DH, Forastiere A, Arquette M, et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 2000; 6: 316-23.
12. Peters GJ, Ackland SP. New metabolites in preclinical and clinical development. Exp Opin Invest Drugs 1996; 5: 637-79.
13. Plunkett W, Huang P, Ghandi V. Preclinical characteristics of gemcitabine. Anti-Cancer Drugs 1995; 6(suppl 6): 7-13.
14. Schulz L, Schalhorn A, Wilmanns W, Heinemann V. Synergistic interaction of gemcitabine and 5-fluorouracil in colon cancer cells. Proc Am Soc Clin Oncol 1998; 17: 162 (abstr 965).
15. Bergman AM, Ruiz van Haperen VWT, Veerman G, et al. Synergistic interaction between gemcitabine and cisplatin in vitro. Clin Cancer Res 1996; 2: 521-30.
16. Van Moorsel CJA, Pinedo HM, Veerman G, et al. Mechanism of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines. Br J Cancer 1999; 981-90.
17. Kroep JR, Peters GJ, Van Moorsel CJA, et al. Gemcitabine-cisplatin: a schedule finding study. Ann Oncol 1999; 10: 1503-10.
18. Oettle H, Arning M, Pelzer U, et al. A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer. Ann Oncol 2000; 11: 1267-72.
19. Kok TC. Chemotherapy in esophageal cancer. Cancer 1997; 23: 65-85.
20. Sandler AB, Kindler HL, Einhorn LH, et al. Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastresophageal junction. Ann Oncol 2000; 11: 1161-4.
21. Pipp M, Mulkerin D, Warren D, et al. Phase II trial of Gemcitabine and 5-Fluorouracil in advanced esophageal cancer. Proc Am Soc Clin Oncol 2001; 20: 158 (abstr 630).
22. Kroep JR, Peters GJ, Giaccone G, Pinedo HM, van Groeningen CJ. Phase II study of Cisplatin (CDDP) preceeding Gemcitabine (GEM) in patients with advanced gastric and esophageal cancer. Proc Am Soc Clin Oncol 2000; 19: 266 (abstr 1033).